Interaction between therapeutic interventions for Alzheimer’s disease and physiological Aβ clearance mechanisms
Open Access
- 5 May 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 7, 64
Abstract
Most therapeutic agents are designed to target a molecule or pathway without consideration of the mechanisms involved in the physiological turnover or removal of that target. In light of this and in particular for Alzheimer’s disease, a number of therapeutic interventions are presently being developed/investigated which target the amyloid-β peptide (Aβ). However, the literature has not adequately considered which Aβ physiological clearance pathways are necessary and sufficient for the effective action of these therapeutics. In this review, we evaluate the therapeutic strategies targeting Aβ presently in clinical development, discuss the possible interaction of these treatments with pathways that under normal physiological conditions are responsible for the turnover of Aβ and highlight possible caveats. We consider immunization strategies primarily reliant on a peripheral sink mechanism of action, small molecules that are reliant on entry into the CNS and thus degradation pathways within the brain as well as lifestyle interventions that affect vascular, parenchymal and peripheral degradation pathways. We propose that effective development of Alzheimer’s disease therapeutic strategies targeting Aβ peptide will require consideration of the age- and disease-specific changes to endogenous Aβ clearance mechanisms in order to elicit maximal efficacy.Keywords
This publication has 193 references indexed in Scilit:
- The role of microglia in amyloid clearance from the AD brainJournal of Neural Transmission, 2010
- Continuous positive airway pressure deepens sleep in patients with Alzheimer’s disease and obstructive sleep apneaSleep Medicine, 2009
- Caloric restriction improves memory in elderly humansProceedings of the National Academy of Sciences, 2009
- Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebral amyloid angiopathyProceedings of the National Academy of Sciences, 2009
- Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic miceProceedings of the National Academy of Sciences, 2007
- The “Perivascular Pump” Driven by Arterial Pulsation Is a Powerful Mechanism for the Distribution of Therapeutic Molecules within the BrainMolecular Therapy, 2006
- Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse modelNature Medicine, 2006
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993